Physician profile
Samuel Bekar
NPI 1184624827
$428.32
in general payments reported to CMS, 2019-2025
8 companies · $46.69 in 2025
The $46.69 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $80.57 · 2021: $20.78 · 2022: $54.41 · 2024: $53.20 · 2025: $46.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $291.73 | 2019-2024 | Bexsero |
| Alk-Abello, INC | $32.81 | 2024-2025 | Odactra, Ragwitek, Grastek |
| Sanofi Pasteur INC. | $20.78 | 2021 | |
| Shire North American Group INC | $18.57 | 2019 | |
| Lnhc, INC | $17.85 | 2025 | Zelsuvmi |
| Genentech USA, INC. | $16.32 | 2022 | |
| Meridian Bioscience INC. | $15.67 | 2019 | |
| Cranial Technologies, INC | $14.59 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Bekar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.